Influenza Vaccines
"Influenza Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed or attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.
Descriptor ID |
D007252
|
MeSH Number(s) |
D20.215.894.899.302
|
Concept/Terms |
Influenza Vaccines- Influenza Vaccines
- Vaccines, Influenza
- Influenzavirus Vaccines
- Vaccines, Influenzavirus
- Influenza Virus Vaccines
- Vaccines, Influenza Virus
- Virus Vaccines, Influenza
- Flu Vaccines
- Vaccines, Flu
- Influenza Vaccine
- Vaccine, Influenza
FluMist- FluMist
- MedImmune Vaccines Brand of Trivalent Live Attenuated Influenza Vaccine
- CAIV-T vaccine
|
Below are MeSH descriptors whose meaning is more general than "Influenza Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Influenza Vaccines".
This graph shows the total number of publications written about "Influenza Vaccines" by people in this website by year, and whether "Influenza Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1984 | 1 | 0 | 1 | 1986 | 0 | 1 | 1 | 1993 | 1 | 0 | 1 | 1994 | 0 | 1 | 1 | 1995 | 2 | 0 | 2 | 1996 | 1 | 1 | 2 | 1997 | 1 | 2 | 3 | 1999 | 2 | 2 | 4 | 2000 | 3 | 2 | 5 | 2001 | 1 | 0 | 1 | 2002 | 3 | 0 | 3 | 2003 | 3 | 0 | 3 | 2004 | 1 | 0 | 1 | 2005 | 0 | 1 | 1 | 2006 | 4 | 2 | 6 | 2007 | 3 | 0 | 3 | 2008 | 2 | 2 | 4 | 2009 | 4 | 0 | 4 | 2010 | 3 | 1 | 4 | 2011 | 6 | 1 | 7 | 2012 | 3 | 1 | 4 | 2013 | 3 | 1 | 4 | 2014 | 6 | 3 | 9 | 2015 | 7 | 3 | 10 | 2016 | 2 | 1 | 3 | 2017 | 4 | 2 | 6 | 2018 | 8 | 3 | 11 | 2019 | 9 | 3 | 12 | 2020 | 6 | 2 | 8 | 2021 | 3 | 3 | 6 | 2022 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Influenza Vaccines" by people in Profiles.
-
Gu M, Taylor B, Pollack HA, Schneider JA, Zaller N. A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US. PLoS One. 2022; 17(6):e0269320.
-
Hernandez-Davies JE, Dollinger EP, Pone EJ, Felgner J, Liang L, Strohmeier S, Jan S, Albin TJ, Jain A, Nakajima R, Jasinskas A, Krammer F, Esser-Kahn A, Felgner PL, Nie Q, Davies DH. Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants. Sci Rep. 2022 06 02; 12(1):9198.
-
Li L, Changrob S, Fu Y, Stovicek O, Guthmiller JJ, McGrath JJC, Dugan HL, Stamper CT, Zheng NY, Huang M, Wilson PC. Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens. Brief Bioinform. 2022 03 10; 23(2).
-
Dugan HL, Wilson PC. Teach 'em young: Influenza vaccines induce broadly neutralizing antibodies in children. Cell Rep Med. 2022 02 15; 3(2):100531.
-
Wen FT, Malani A, Cobey S. The Potential Beneficial Effects of Vaccination on Antigenically Evolving Pathogens. Am Nat. 2022 02; 199(2):223-237.
-
Guthmiller JJ, Han J, Utset HA, Li L, Lan LY, Henry C, Stamper CT, McMahon M, O'Dell G, Fernández-Quintero ML, Freyn AW, Amanat F, Stovicek O, Gentles L, Richey ST, de la Peña AT, Rosado V, Dugan HL, Zheng NY, Tepora ME, Bitar DJ, Changrob S, Strohmeier S, Huang M, García-Sastre A, Liedl KR, Bloom JD, Nachbagauer R, Palese P, Krammer F, Coughlan L, Ward AB, Wilson PC. Broadly neutralizing antibodies target a haemagglutinin anchor epitope. Nature. 2022 02; 602(7896):314-320.
-
Guthmiller JJ, Utset HA, Henry C, Li L, Zheng NY, Sun W, Costa Vieira M, Zost S, Huang M, Hensley SE, Cobey S, Palese P, Wilson PC. An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines. mBio. 2021 06 29; 12(3):e0083821.
-
Guthmiller JJ, Han J, Li L, Freyn AW, Liu STH, Stovicek O, Stamper CT, Dugan HL, Tepora ME, Utset HA, Bitar DJ, Hamel NJ, Changrob S, Zheng NY, Huang M, Krammer F, Nachbagauer R, Palese P, Ward AB, Wilson PC. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Sci Transl Med. 2021 06 02; 13(596).
-
Guthmiller JJ, Utset HA, Wilson PC. B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat. Viruses. 2021 05 22; 13(6).
-
Freyn AW, Han J, Guthmiller JJ, Bailey MJ, Neu K, Turner HL, Rosado VC, Chromikova V, Huang M, Strohmeier S, Liu STH, Simon V, Krammer F, Ward AB, Palese P, Wilson PC, Nachbagauer R. Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|